Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. 1987

D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.

Chloroquine-resistant Plasmodium falciparum accumulate significantly less chloroquine than susceptible parasites, and this is thought to be the basis of their resistance. However, the reason for the lower accumulation of chloroquine was unknown. The resistant parasite has now been found to release chloroquine 40 to 50 times more rapidly than the susceptible parasite, although their initial rates of chloroquine accumulation are the same. Verapamil and two other calcium channel blockers, as well as vinblastine and daunomycin, each slowed the release and increased the accumulation of chloroquine by resistant (but not susceptible) Plasmodium falciparum. These results suggest that a higher rate of chloroquine release explains the lower chloroquine accumulation, and thus the resistance observed in resistant Plasmodium falciparum.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine

Related Publications

D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
November 2010, PloS one,
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
May 1961, The American journal of tropical medicine and hygiene,
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
January 1972, Transactions of the Royal Society of Tropical Medicine and Hygiene,
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
January 1993, Pharmacology & therapeutics,
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
September 1983, The American journal of tropical medicine and hygiene,
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
August 2003, Biochemistry,
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
January 1973, Transactions of the Royal Society of Tropical Medicine and Hygiene,
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
January 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene,
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
August 1987, Parasitology today (Personal ed.),
D J Krogstad, and I Y Gluzman, and D E Kyle, and A M Oduola, and S K Martin, and W K Milhous, and P H Schlesinger
October 2011, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!